Literature DB >> 20067428

Low-mannose-binding lectin levels in susceptibility to neonatal sepsis in preterm neonates with fetal inflammatory response syndrome.

Ozgur Ozdemir1, Ener Cagri Dinleyici, Neslihan Tekin, Omer Colak, M Arif Aksit.   

Abstract

AIM: In this study, we aimed to evaluate cord blood mannose binding levels (MBL), to evaluate possible relationship between cord blood MBL levels with neonatal sepsis and culture confirmed neonatal sepsis in preterm newborn with gestational age below 34 weeks with fetal inflammatory response syndrome (FIRS).
METHODS: Forty-four randomly selected < or =34 weeks gestational age newborns with FIRS were evaluated. MBL deficiency was described as cord blood levels were below 400 ng/ml.
RESULTS: Mean value of umbilical cord MBL was significantly lower in newborns with culture confirmed sepsis (p < 0.01) and also all cases with sepsis (including culture negative or positive) (p < 0.05) than newborns without sepsis. Culture-confirmed sepsis was statistically common in MBL deficient premature newborns with FIRS. Univariate analysis showed that gestational age, birth weight, low serum MBL level and poor obstetric history were all significantly associated with the risk of neonatal sepsis. A subsequent multivariate analysis showed that the association between serum MBL level and the risk of suspected sepsis and culture confirmed sepsis independently from gestational age and birth weight.
CONCLUSION: Here in, we report firstly lower MBL levels were found related with sepsis in neonates, especially in newborns with culture proven sepsis. Low MBL levels may help to identify neonates with FIRS at high risk of developing sepsis.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20067428     DOI: 10.3109/14767050903551418

Source DB:  PubMed          Journal:  J Matern Fetal Neonatal Med        ISSN: 1476-4954


  8 in total

1.  Use of Mannose-Binding Lectin Gene Polymorphisms and the Serum MBL Level for the Early Detection of Neonatal Sepsis.

Authors:  Magda Badawy; Dalia S Mosallam; Doaa Saber; Hanan Madani
Journal:  J Pediatr Genet       Date:  2018-11-09

2.  Characterization of the fetal blood transcriptome and proteome in maternal anti-fetal rejection: evidence of a distinct and novel type of human fetal systemic inflammatory response.

Authors:  Joonho Lee; Roberto Romero; Tinnakorn Chaiworapongsa; Zhong Dong; Adi L Tarca; Yi Xu; Po Jen Chiang; Juan Pedro Kusanovic; Sonia S Hassan; Lami Yeo; Bo Hyun Yoon; Nandor Gabor Than; Chong Jai Kim
Journal:  Am J Reprod Immunol       Date:  2013-07-30       Impact factor: 3.886

3.  Relationship of serum mannose-binding lectin levels with the development of sepsis: a meta-analysis.

Authors:  Dong-Na Gao; Yu Zhang; Yan-Bo Ren; Jian Kang; Li Jiang; Zhuo Feng; Ya-Nan Qu; Qing-Hui Qi; Xuan Meng
Journal:  Inflammation       Date:  2015-02       Impact factor: 4.092

Review 4.  Factors of the lectin pathway of complement activation and their clinical associations in neonates.

Authors:  Maciej Cedzynski; Anna St Swierzko; David C Kilpatrick
Journal:  J Biomed Biotechnol       Date:  2012-03-22

5.  Monocyte differentiation and macrophage priming are regulated differentially by pentraxins and their ligands.

Authors:  Darrell Pilling; Elkin Galvis-Carvajal; Tejas R Karhadkar; Nehemiah Cox; Richard H Gomer
Journal:  BMC Immunol       Date:  2017-06-15       Impact factor: 3.615

6.  Effect of prematurity on genome wide methylation in the placenta.

Authors:  Jessica Schuster; Alper Uzun; Joan Stablia; Christoph Schorl; Mari Mori; James F Padbury
Journal:  BMC Med Genet       Date:  2019-06-28       Impact factor: 2.103

Review 7.  The role of mannose-binding lectin in severe sepsis and septic shock.

Authors:  Gennaro De Pascale; Salvatore Lucio Cutuli; Mariano Alberto Pennisi; Massimo Antonelli
Journal:  Mediators Inflamm       Date:  2013-10-02       Impact factor: 4.711

8.  iTRAQ plasma proteomics analysis for candidate biomarkers of type 2 incipient diabetic nephropathy.

Authors:  Hongmei Lu; Shaodong Deng; Minghui Zheng; Kunhua Hu
Journal:  Clin Proteomics       Date:  2019-07-31       Impact factor: 3.988

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.